R&D Changing Faces: Board appointments, June and July 2026 Board appointments June/July brought together veterans from across the pharmaceutical industry, venture capital, healthcare technology, and academia
Sales & Marketing Changing Faces: Agency, consultancy, and investor hires, Jun... Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.
Digital Changing Faces: Digital and supplier hires, June and July 20... The pharma-adjacent tech and services sectors continued to attract experienced leadership talent during June and July.
R&D Changing Faces: Pharma and biotech hires, June & July 2026 In June/July, companies continued to reshape their leadership teams in preparation for upcoming clinical, regulatory, and commercial milestones.
News Cavanaugh to replace Taubert as J&J's pharma head Jennifer Taubert will hand over the reins of Johnson & Johnson's Innovative Medicines division to Tom Cavanaugh after she retires on 1st September.
News Sobi's long-serving CEO Guido Oelkers to step down After nearly a decade in the role, Guido Oelkers is stepping down as chief executive of Sobi to take the top job at BioNTech.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.